John Byrd, M.D., Ching-Shih Chen, Ph.D., Michael Freitas, Ph.D., Michael Grever, Ph.D., Samual Kulp, Ph.D., David Lucas, Ph.D., Mark R. Parthun, Ph.D., Amy Sklenar, B.S., Xiaodan Su, Ph.D.
Partially funded by Cardinal Health
Location: The Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute - Ohio
Proposal: Chromatin regulation as a therapeutic target to enhance biologic therapies in Chronic Lymphocytic Leukemia (CLL)
